Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting
  • CME

Hanny Al-Samkari, MD
Rami S. Komrokji, MD
Sagar Lonial, MD
Jeff P. Sharman, MD
Sujit Sheth, MD
Eunice S. Wang, MD
Released: March 17, 2020
Back Next

Introduction

In these highlights from the ClinicalThought program, expert faculty members Jeff P. Sharman, MD; Hanny Al-Samkari, MD; Sujit Sheth, MD; Eunice S. Wang, MD; Rami S. Komrokji, MD; and Sagar Lonial, MD highlight key findings in chronic lymphocytic leukemia (CLL) and lymphomas, leukemias, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs), multiple myeloma (MM), and nonmalignant hematologic disorders presented at the 2019 ASH annual meeting.

CCO plans to measure the educational impact of this activity, and some questions in this activity will be asked twice: once before the discussion that informs the best choice and then once again after that specific discussion. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by the Annenberg Center for Health Sciences at Eisenhower in partnership with Clinical Care Options.
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
AstraZeneca
Celgene Corporation
Dova Pharmaceuticals, Inc.
Karyopharm Therapeutics
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue